About Zenas BioPharma
Zenas BioPharma is a private company based in Waltham, Massachusetts, incorporated in 2023 in Delaware. It has reported $384,044,167 raised in two offerings on Form D since November 2022.
Funding Rounds (SEC Form D)
| First sale | Filed with SEC | Amount sold | Investors | Avg. check | Terms | Filing |
|---|---|---|---|---|---|---|
| May 3, 2024 | May 14, 2024 | $200,145,732fully sold | 26 | $7.6M | Equity, Securities on exerciseRule 506(b) | Form D ↗ |
| Nov 2, 2022 | Nov 15, 2022 | $183,898,435fully sold | 17 | $10.8M | EquityRule 506(b) | Form D ↗ |
| Total, two offerings | $384,044,167 | |||||
First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.
Leadership Team
Executive officers and directors listed on Zenas BioPharma's Form D filed May 14, 2024.
PE
TK
PA
Patricia Allen
Director
JF
Joseph Farmer
PRESIDENT and CHIEF OPERATING OFFICER
LJ
Leon Moulder, Jr.
Executive officer and director
JN
Jake Nunn
Director
TX
Tim Xiao
Director
JF
Jennifer Fox
Executive officer
JB
James Boylan
Director
TF
Tanya Fischer
Executive officer
JO
John Orloff
Director
HL
Earlier filings also listed Marietta Wu (director, last listed Nov 2022) and Hua Mu (executive officer and director, last listed Nov 2022).